Cargando…

Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis

PURPOSE: Although oral prednisolone is the first-line treatment for preventing recurrent optic neuritis (ON) after the completion of acute-phase treatment, especially anti-aquaporin 4 (AQP4) antibody-positive ON, and anti-myelin oligodendrocyte glycoprotein (MOG) antibody-positive ON, some patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mori, Sotaro, Kurimoto, Takuji, Murai, Yusuke, Ueda, Kaori, Sakamoto, Mari, Chihara, Norio, Yamada-Nakanishi, Yuko, Nakamura, Makoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883711/ https://www.ncbi.nlm.nih.gov/pubmed/33628473 http://dx.doi.org/10.1155/2020/8871146

Ejemplares similares

Optic Neuritis Possibly Induced by Anti-PD-L1 Antibody Treatment in a Patient with Non-Small Cell Lung Carcinoma
por: Mori, Sotaro, et al.
Publicado: (2018)

A case of neurosarcoidosis presenting with multiple cranial neuropathies
por: Mori, Sotaro, et al.
Publicado: (2020)

Impact of the anti-aquaporin-4 autoantibody on inner retinal structure, function and structure-function associations in Japanese patients with optic neuritis
por: Matsumoto, Yoshiko, et al.
Publicado: (2017)

A comparison of the 1-year surgical outcomes of ab externo trabeculotomy and microhook ab interno trabeculotomy using propensity score analysis
por: Mori, Sotaro, et al.
Publicado: (2020)

Granulomatosis with Polyangiitis Presenting with Bilateral Orbital Apex Syndrome
por: Murai, Yusuke, et al.
Publicado: (2021)

Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?
por: Stiebel-Kalish, Hadas, et al.
Publicado: (2019)

The beneficial impact of filtration surgery on antiviral therapy cessation in patients with cytomegalovirus-related secondary glaucoma
por: Murai, Yusuke, et al.
Publicado: (2021)

Protocol to test the efficacy and safety of frequent applications of skin electrical stimulation for Leber hereditary optic neuropathy: a single-arm, open-label, non-randomised prospective study
por: Ueda, Kaori, et al.
Publicado: (2021)

Uveitis, optic neuritis and MOG
por: Gupta, Pranjal, et al.
Publicado: (2020)

Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis
por: Chalmoukou, Konstantina, et al.
Publicado: (2015)

A study protocol for evaluating the efficacy and safety of skin electrical stimulation for Leber hereditary optic neuropathy: a single-arm, open-label, non-randomized prospective exploratory study
por: Kurimoto, Takuji, et al.
Publicado: (2019)

Prevalence of serum MOG antibody and AQP4 antibody in optic neuritis after SARS-CoV-2 infection
por: Sun, Chuan-bin
Publicado: (2023)

Transient Tunnel Vision as Initial Presentation of Anti-MOG Antibody Positive Optic Neuritis
por: Prabhakar, Appaswamy T., et al.
Publicado: (2021)

A Single-Arm, Prospective, Exploratory Study to Preliminarily Test Effectiveness and Safety of Skin Electrical Stimulation for Leber Hereditary Optic Neuropathy
por: Kurimoto, Takuji, et al.
Publicado: (2020)

Transient optic neuritis and perineuritis associated with anti-MOG antibody after SARS-CoV-2 mRNA vaccination
por: Singu, Takaomi, et al.
Publicado: (2022)

MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis
por: Wildemann, Brigitte, et al.
Publicado: (2020)

Pattern Visually Evoked Potentials in Japanese Girl With Optic Neuritis and Seropositive to Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Takano, Shunichiro, et al.
Publicado: (2019)

A Longitudinal Comparison of the Recovery Patterns of Optic Neuritis with MOG Antibody-Seropositive and AQP4 Antibody-Seropositive or -Seronegative for Both Antibodies
por: Zhou, Lin, et al.
Publicado: (2022)

The Difficulty of Diagnosing Invasive Aspergillosis Initially Manifesting as Optic Neuropathy
por: Mori, Sotaro, et al.
Publicado: (2019)

Meningitis as a recurrent manifestation of anti-AQP4/anti-MOG negative neuromyelitis optica spectrum disorder: a case report
por: Zhang, Chenyang, et al.
Publicado: (2021)

Structural and Functional Alterations in Visual Pathway After Optic Neuritis in MOG Antibody Disease: A Comparative Study With AQP4 Seropositive NMOSD
por: Gao, Chenyang, et al.
Publicado: (2021)

Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

MOG-IgG- versus AQP4-IgG-Positive Optic Neuritis in Thailand: Clinical Characteristics and Long-Term Visual Outcomes Comparison
por: Narongkhananukul, Chanomporn, et al.
Publicado: (2020)

Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood
por: Chen, Xuelian, et al.
Publicado: (2023)

T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity
por: Sagan, Sharon A., et al.
Publicado: (2023)

Relapsing optic neuritis and meningoencephalitis in a child: case report of delayed diagnosis of MOG-IgG syndrome
por: Zhong, Xiaonan, et al.
Publicado: (2019)

Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study
por: Stiebel-Kalish, Hadas, et al.
Publicado: (2017)

Corrigendum: Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood
por: Chen, Xuelian, et al.
Publicado: (2023)

Anti-MOG Positive Bilateral Optic Neuritis and Brainstem Encephalitis Secondary to COVID-19 Infection: A Case Report
por: Tsouris, Zisis, et al.
Publicado: (2022)

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies
por: Yeo, Tianrong, et al.
Publicado: (2020)

Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody–Associated Diseases
por: Avouac, Alexandre, et al.
Publicado: (2021)

Differences in Neuropathic Pain and Radiological Features Between AQP4-ON, MOG-ON, and IDON
por: Kang, Hao, et al.
Publicado: (2022)

Vasculitis with superior ophthalmic vein thrombosis compatible with neuro-neutrophilic disease
por: Sakamoto, Mari, et al.
Publicado: (2018)

Excessive scleral shrinkage, rather than choroidal thickening, is a major contributor to the development of hypotony maculopathy after trabeculectomy
por: Sakamoto, Mari, et al.
Publicado: (2018)

Myelin Oligodendrocyte Glycoprotein (MOG) Optic Neuritis: A Case Series
por: Nurul-Ain, Masnon, et al.
Publicado: (2021)

Comparison of spontaneous brain activity revealed by regional homogeneity in AQP4-IgG neuromyelitis optica-optic neuritis versus MOG-IgG optic neuritis patients: a resting-state functional MRI study
por: Wang, Junqing, et al.
Publicado: (2017)

AQP4-IgG and MOG-IgG Related Optic Neuritis—Prevalence, Optical Coherence Tomography Findings, and Visual Outcomes: A Systematic Review and Meta-Analysis
por: Filippatou, Angeliki G., et al.
Publicado: (2020)

Rebound of relapses after discontinuation of rituximab in a patient with MOG-IgG1 positive highly relapsing optic neuritis: a case report
por: Choi, Seok-Jin, et al.
Publicado: (2018)

A Case of Multi-System Langerhans Cell Histiocytosis with Local Invasion of the Orbital Apex
por: Yamada, Hiroko, et al.
Publicado: (2019)

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients
por: Pache, Florence, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_onqhbrib8fu30b4ovs2tsoh09r